“The medical device tax was one of many factors that contributed to the rationale for the realignment of our business, which resulted in the reduction of operating expenses,” St. Jude spokeswoman Amy Jo Meyer told the Minneapolis Star Tribune.
The medical device giant announced last week that it terminated 300 employees, effective immediately, and that the company was undertaking a massive overhaul to structure its businesses from 4 divisions into 2: the Implantable Electronic Systems Division and the Cardiovascular and Ablation Technologies Division.
Tandem Diabetes Care announced that it would begin shipping its 1st t:slim insulin pumps, the touch-screen insulin pumps with FDA clearance for the U.S. market.
Australian scientists implants 1st bionic eye
Australia’s government-funded Bionic Vision Australia implanted a patients with the “world’s 1st” pre-bionic eye prototype, which contains 24 electrodes and connects to the retina to send electrical impulses that stimulate nerve cells.
Hospitals get into the insurance game
Under pressure from public and private insurers and employers to accept flat-rate payments for care, hospitals look to flip their business models to behavior more like insurers and encourage preventative care.
Stents provide better outcomes than drug therapy for certain patients
Early stent use may beat drug therapy in lowering the risk of re-hospitalization in patients with stable coronary artery disease and narrowed blood vessels that compromise blood flow to the heart, researchers say.